Drug trial offers new hope for severely obese kids
NCT ID NCT02273804
Summary
This study tested whether adding the medication Topiramate to standard obesity treatment helps reduce body mass index (BMI) more than standard treatment alone in severely obese children and teens. The 9-month trial compared Topiramate against a placebo in participants aged 9-17. The goal was to see if this already-approved neurological medication could safely help control severe childhood obesity.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESE CHILDREN AND ADOLESCENTS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hopital Bicêtre
Le Kremlin-Bicêtre, Paris, 94275, France
Conditions
Explore the condition pages connected to this study.